NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $473,215 | +3.8% | 4,646 | +2.9% | 0.02% | +4.3% |
Q2 2023 | $455,856 | +20.8% | 4,517 | +10.1% | 0.02% | +9.5% |
Q1 2023 | $377,486 | +2.6% | 4,103 | +1.1% | 0.02% | -4.5% |
Q4 2022 | $368,034 | -3.4% | 4,057 | -19.1% | 0.02% | 0.0% |
Q3 2022 | $381,000 | -2.3% | 5,012 | +8.5% | 0.02% | -4.3% |
Q2 2022 | $390,000 | -12.8% | 4,618 | -9.4% | 0.02% | +9.5% |
Q1 2022 | $447,000 | +1.4% | 5,098 | +1.2% | 0.02% | 0.0% |
Q4 2021 | $441,000 | +2.8% | 5,037 | -4.0% | 0.02% | -4.5% |
Q3 2021 | $429,000 | +15.0% | 5,249 | +28.5% | 0.02% | +15.8% |
Q2 2021 | $373,000 | +14.4% | 4,085 | +7.0% | 0.02% | 0.0% |
Q1 2021 | $326,000 | -14.7% | 3,816 | -5.7% | 0.02% | -20.8% |
Q4 2020 | $382,000 | +9.5% | 4,046 | +0.8% | 0.02% | 0.0% |
Q3 2020 | $349,000 | +66.2% | 4,014 | +67.0% | 0.02% | +41.2% |
Q2 2020 | $210,000 | -27.1% | 2,404 | -31.1% | 0.02% | -43.3% |
Q1 2020 | $288,000 | -9.1% | 3,491 | +4.4% | 0.03% | -11.8% |
Q4 2019 | $317,000 | +21.0% | 3,343 | +10.7% | 0.03% | +9.7% |
Q3 2019 | $262,000 | -5.4% | 3,019 | -0.6% | 0.03% | -3.1% |
Q2 2019 | $277,000 | -21.5% | 3,038 | -17.2% | 0.03% | -25.6% |
Q1 2019 | $353,000 | +33.7% | 3,670 | +19.1% | 0.04% | +13.2% |
Q4 2018 | $264,000 | -1.1% | 3,082 | -0.6% | 0.04% | +15.2% |
Q3 2018 | $267,000 | +13.6% | 3,101 | -0.4% | 0.03% | +10.0% |
Q2 2018 | $235,000 | -13.3% | 3,115 | -6.9% | 0.03% | -18.9% |
Q1 2018 | $271,000 | -5.2% | 3,346 | -1.8% | 0.04% | +5.7% |
Q4 2017 | $286,000 | +8.3% | 3,408 | +11.0% | 0.04% | +2.9% |
Q3 2017 | $264,000 | +0.4% | 3,071 | -2.4% | 0.03% | -8.1% |
Q2 2017 | $263,000 | -99.9% | 3,148 | -9.4% | 0.04% | -15.9% |
Q3 2016 | $274,376,000 | +95835.7% | 3,475 | +0.1% | 0.04% | -13.7% |
Q2 2016 | $286,000 | -99.9% | 3,470 | +19.4% | 0.05% | +30.8% |
Q1 2016 | $210,543,000 | +85486.6% | 2,906 | +16.1% | 0.04% | -30.4% |
Q2 2015 | $246,000 | +0.4% | 2,503 | +0.6% | 0.06% | +1.8% |
Q1 2015 | $245,000 | +8.4% | 2,487 | +2.1% | 0.06% | +5.8% |
Q4 2014 | $226,000 | -9.6% | 2,437 | -8.4% | 0.05% | -7.1% |
Q3 2014 | $250,000 | +1.6% | 2,660 | -2.2% | 0.06% | 0.0% |
Q2 2014 | $246,000 | -7.9% | 2,721 | -13.3% | 0.06% | -11.1% |
Q1 2014 | $267,000 | +9.9% | 3,140 | -8.8% | 0.06% | -13.7% |
Q2 2013 | $243,000 | – | 3,443 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |